Evelo Biosciences Sees Unusually Large Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLOGet Free Report) was the recipient of unusually large options trading on Wednesday. Investors acquired 1,885 put options on the company. This represents an increase of approximately 1,101% compared to the average volume of 157 put options.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Evelo Biosciences stock. Vanguard Group Inc. increased its stake in Evelo Biosciences, Inc. (NASDAQ:EVLOFree Report) by 129.5% during the third quarter, according to its most recent filing with the SEC. The fund owned 357,711 shares of the company’s stock after buying an additional 201,815 shares during the quarter. Vanguard Group Inc. owned 1.88% of Evelo Biosciences worth $1,402,000 at the end of the most recent quarter. 0.31% of the stock is owned by institutional investors.

Evelo Biosciences Price Performance

The firm has a 50-day simple moving average of $0.03 and a 200 day simple moving average of $0.05. Evelo Biosciences has a twelve month low of $0.00 and a twelve month high of $13.93.

About Evelo Biosciences

(Get Free Report)

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.

Recommended Stories

Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.